Trial NCT00499369

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-00784
Secondary IDs: CALGB-SWOG-S0600 CAN-NCIC-SWOG-S0600 CDR0000551934 ECOG-SWOG-S0600 NCCTG-SWOG-S0600 NCI-2009-00784 S0600 SWOG-S0600 U10CA032102

Last trial update was posted on 2014-07-31

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Cetuximab Fluorouracil Immunoglobulins Irinotecan Leucovorin Levoleucovorin

MeSH Conditions

Colonic Neoplasms Rectal Neoplasms Recurrence

Other Conditions

Recurrent Colon Cancer Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer

Stopping Reasons

Due to inadequate accrual, study was terminated and limited outcome data was reported.

Limitations And Caveats

Due to inadequate accrual, study was terminated and limited outcome data was reported.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID